MX9706188A - Inhibicion de la angiogenesis usando interleucina 12. - Google Patents

Inhibicion de la angiogenesis usando interleucina 12.

Info

Publication number
MX9706188A
MX9706188A MX9706188A MX9706188A MX9706188A MX 9706188 A MX9706188 A MX 9706188A MX 9706188 A MX9706188 A MX 9706188A MX 9706188 A MX9706188 A MX 9706188A MX 9706188 A MX9706188 A MX 9706188A
Authority
MX
Mexico
Prior art keywords
interleukin
angiogenesis
inhibition
treatment
undesired
Prior art date
Application number
MX9706188A
Other languages
English (en)
Other versions
MXPA97006188A (es
Inventor
Moses Judah Folkman
Gary Arthur Truitt
Emile Eugene Voest
Original Assignee
Hoffmann La Roche
Children S Medical Ct
Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche, Children S Medical Ct, Corp filed Critical Hoffmann La Roche
Publication of MX9706188A publication Critical patent/MX9706188A/es
Publication of MXPA97006188A publication Critical patent/MXPA97006188A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invencion se relaciona con el uso de la interleucina 12 para la preparacion de un medicamento para el tratamiento de la angiogénesis indeseable o no controlada, el cual es importante en el tratamiento de la retinopatía diabética y degeneracion.
MXPA/A/1997/006188A 1995-02-16 1997-08-13 Inhibicion de la angiogenesis usando interleucina12 MXPA97006188A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38938295A 1995-02-16 1995-02-16
US389382 1995-02-16
PCT/EP1996/000507 WO1996025171A1 (en) 1995-02-16 1996-02-07 Inhibition of angiogenesis using interleukin-12

Publications (2)

Publication Number Publication Date
MX9706188A true MX9706188A (es) 1997-11-29
MXPA97006188A MXPA97006188A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
JPH11500119A (ja) 1999-01-06
TR199700801T1 (xx) 1998-03-21
EP0809511A1 (en) 1997-12-03
AU4788396A (en) 1996-09-04
FI973356A0 (fi) 1997-08-15
FI973356A (fi) 1997-08-15
WO1996025171A1 (en) 1996-08-22
CA2212370A1 (en) 1996-08-22
BR9607427A (pt) 1998-06-23

Similar Documents

Publication Publication Date Title
HUT74452A (en) Preparation for substitution therapy, containing at least one progestogen and at least one extrogen
IL136839A0 (en) Pharmaceutical compositions comprising cannabidiol derivatives
WO2002058684A3 (en) Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
PL312219A1 (en) Application of nona- and decapeptides in obtaining a therapeutic agent for fighting against aids
HU9603042D0 (en) Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration
AU685075B2 (en) Pharmaceutical composition for treating nicotine dependence
AU693833B2 (en) Products containing G-CSF and TNF binding protein
TR199700801T1 (xx) İnterleukin 12 kullanılarak angiogenesisin önlenmesi.
TW261532B (es)
ES8707488A1 (es) Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
WO1999051256A3 (en) Use of l-glu-l-trp in the treatment of hiv infection
EP0744176A3 (en) Methods for inhibiting bone loss
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
GR1002576B (el) Φαρμακευτικες συνθεσεις και μια μεθοδος παρασκευης τους.
AU5061090A (en) Aids therapy
AU7718796A (en) 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus
IL97734A0 (en) Benzoxazine derivatives,process for their preparation and their use for treatment or for the prophylaxis of diseases
NZ268039A (en) Use of efaroxan in treating parkinson's disease
AU2002225097A1 (en) Novel therapeutic use of a thienylcyclohexylamine derivative
AU5903690A (en) Use in therapy of 10-amino-5,6-dihydro-11h-dibenzo(b,e) azepine-6, 11-dione and derivatives as drugs for use in the treatment of urinary incontinence
WO1998024421A3 (en) Use of dextrin sulphate for the treatment of highly vascular tumours
UA43800A (uk) Спосіб лікування перфоративної виразки дванадцятипалої кишки
IL123382A0 (en) Preparation for the prophylaxis and/or treatment of wool and hair loss
UA10754A (uk) Спосіб лікуваhhя артеріальhих гіпертеhзій різhого геhезу
UA20026A (uk) Спосіб профілактики та лікуваhhя катаракти